Pharmaceutical Environmental Risk Assessment

Home→ERA Profiles → Cloprednol→

Cloprednol Environmental Risk Assessment (ERA) report

Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.

CAS Registry Number
5251-34-3
Molecular formula
C21H25ClO5
Molecular weight
392.9 g/mol
Drug class
Synthetic glucocorticoidcorticosteroid receptor agonist
Mechanism of action
Activates glucocorticoid receptors and suppresses inflammatory gene expression, cytokine production and immune-cell activity. Clinical action depends on the specific oral, inhaled or topical formulation.
Indications / reported uses
  • Treatment of corticosteroid-responsive inflammatory and allergic disorders in countries where cloprednol products are authorised; specific indication is route- and product-specific

Sources: NLM MeSH — Cloprednol · PubMed — Cloprednol glucocorticoid pharmacology · FDA product information

View request basketPrefer email? info@toxwriter.com
Phase IPhase II where requiredEU / UK / other markets
Assessment scope

Environmental Risk Assessment (ERA)

ToxWriter provides project-specific support for the Cloprednol Environmental Risk Assessment (ERA) (the Cloprednol ERA report). The required pathway is determined by the medicinal product, active-substance form, route, intended market, use assumptions and available environmental evidence.

Assessment may cover

  • Product, active-substance identity, formulation, route and intended-market review.
  • Phase I environmental exposure screening and applicable trigger evaluation.
  • Phase II environmental fate and ecotoxicity assessment where required by the applicable pathway.
  • PEC/PNEC risk characterisation and PBT/vPvB considerations where relevant and supported by evidence.
  • Data-gap analysis, study strategy, assumptions and scientific reporting.
ERA regulatory framework

The EMA guideline sets out the EU framework for environmental risk assessment of human medicinal products. MHRA guidance describes UK expectations; the applicable scope depends on the product and submission context.